Global Canine Atopic Dermatitis Treatment Market Size, Status and Forecast 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Canine Atopic Dermatitis Treatment Quarterly Market Size Analysis
- 2.1 Canine Atopic Dermatitis Treatment Business Impact Assessment - COVID-19
- 2.1.1 Global Canine Atopic Dermatitis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Canine Atopic Dermatitis Treatment Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Canine Atopic Dermatitis Treatment Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Canine Atopic Dermatitis Treatment Headquarters and Area Served
- 3.3 Date of Key Players Enter into Canine Atopic Dermatitis Treatment Market
- 3.4 Key Players Canine Atopic Dermatitis Treatment Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Canine Atopic Dermatitis Treatment Segments, By Type
- 4.1 Introduction
- 1.4.1 Antihistamines
- 1.4.2 Immunosuppressants
- 1.4.3 Corticosteroids
- 1.4.4 Antibiotics
- 1.4.5 Emollient
- 1.4.6 Other
- 4.2 By Type, Global Canine Atopic Dermatitis Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Canine Atopic Dermatitis Treatment Segments, By Application
- 5.1 Overview
- 5.5.1 Oral
- 5.5.2 Topical
- 5.5.3 Injectable
- 5.2 By Application, Global Canine Atopic Dermatitis Treatment Market Size, 2019-2021
- 5.2.1 By Application, Global Canine Atopic Dermatitis Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Business Overview
- 7.1.2 Zoetis Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.1.3 Zoetis Canine Atopic Dermatitis Treatment Product Introduction
- 7.1.4 Zoetis Response to COVID-19 and Related Developments
- 7.2 Virbac
- 7.2.1 Virbac Business Overview
- 7.2.2 Virbac Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.2.3 Virbac Canine Atopic Dermatitis Treatment Product Introduction
- 7.2.4 Virbac Response to COVID-19 and Related Developments
- 7.3 AB Science
- 7.3.1 AB Science Business Overview
- 7.3.2 AB Science Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.3.3 AB Science Canine Atopic Dermatitis Treatment Product Introduction
- 7.3.4 AB Science Response to COVID-19 and Related Developments
- 7.4 Toray Industries
- 7.4.1 Toray Industries Business Overview
- 7.4.2 Toray Industries Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.4.3 Toray Industries Canine Atopic Dermatitis Treatment Product Introduction
- 7.4.4 Toray Industries Response to COVID-19 and Related Developments
- 7.5 Novartis
- 7.5.1 Novartis Business Overview
- 7.5.2 Novartis Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.5.3 Novartis Canine Atopic Dermatitis Treatment Product Introduction
- 7.5.4 Novartis Response to COVID-19 and Related Developments
- 7.6 Boehringer Ingelheim
- 7.6.1 Boehringer Ingelheim Business Overview
- 7.6.2 Boehringer Ingelheim Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.6.3 Boehringer Ingelheim Canine Atopic Dermatitis Treatment Product Introduction
- 7.6.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
- 7.7 Elanco Animal Health
- 7.7.1 Elanco Animal Health Business Overview
- 7.7.2 Elanco Animal Health Canine Atopic Dermatitis Treatment Quarterly Revenue, 2020
- 7.7.3 Elanco Animal Health Canine Atopic Dermatitis Treatment Product Introduction
- 7.7.4 Elanco Animal Health Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Canine Atopic Dermatitis Treatment, including the following market information:
Global Canine Atopic Dermatitis Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Canine Atopic Dermatitis Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Canine Atopic Dermatitis Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Canine Atopic Dermatitis Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Zoetis, Virbac, AB Science, Toray Industries, Novartis, Boehringer Ingelheim, Elanco Animal Health, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Antihistamines
Immunosuppressants
Corticosteroids
Antibiotics
Emollient
Other
Based on the Application:
Oral
Topical
Injectable